Results 201 to 210 of about 287,935 (381)

Causes of death in patients with complete heart block and aritificial pacemakers.

, 1968
A Harris, D R Redwood, Michael J. Davies, G. Davies   +3 more
openalex   +1 more source

EXPERIENCE WITH INDUCTIVE COUPLED CARDIAC PACEMAKERS [PDF]

, 1964
L D Abrams, Jim C. Norman
openalex   +1 more source

A phenomap of TTR amyloidosis to aid diagnostic screening

ESC Heart Failure, Volume 12, Issue 2, Page 1113-1118, April 2025.
Abstract Cardiac amyloidosis due to transthyretin (ATTR) remains an underdiagnosed cause of cardiomyopathy. As awareness of the disease grows and referrals for ATTR increase, clinicians are likely to encounter more atypical forms of the condition in clinical practice.
Alexios S. Antonopoulos, Theodoros Tsampras, George Lazaros, Konstantinos Tsioufis, Charalambos Vlachopoulos   +4 more
wiley   +1 more source

The Crucial Role of Physical Activity Index, in Predicting the Incidence of Pacemaker Syndrome. [PDF]

J Arrhythm
Malekrah A, Amiri S, Alipour A, Asgary N.   +3 more
europepmc   +1 more source

A SIMPLIFIED TECHNIQUE IN THE USE OF EXTERNAL CARDIAC PACEMAKERS

, 1964
Jay G. Silverman, Marvin S. Rosenberg
openalex   +1 more source

The Effect of Tetraethylpyrophosphate (TEPP) on the Transmembrane Potentials of Pacemaker and Non-pacemaker Fibers of Isolated Rabbit Atrium [PDF]

, 1960
Morris Kleinfeld, John Magin, Edward Stein   +2 more
openalex   +1 more source

Cardiogenic shock mortality according to Aetiology in a Mediterranean cohort: Results from the Shock‐CAT study

ESC Heart Failure, Volume 12, Issue 2, Page 1336-1345, April 2025.
Abstract Aims Mortality in cardiogenic shock (CS) remains elevated, with the potential for CS causes to impact prognosis and risk stratification. The aim was to investigate in‐hospital prognosis and mortality in CS patients according to aetiology. We also assessed the prognostic accuracy of CardShock and IABP‐SHOCK II scores.
Cosme García‐García, Teresa López‐Sobrino, Esther Sanz‐Girgas, Maria R. Cueto, Jaime Aboal, Pablo Pastor, Irene Buera, Alessandro Sionis, Rut Andrea, Judit Rodríguez‐López, Jose Carlos Sánchez‐Salado, Carlos Tomas, Jordi Bañeras, Albert Ariza, Josep Lupón, Antoni Bayés‐Genís, Ferran Rueda, Grup de Treball de Cures Agudes Cardiològiques Societat Catalana de Cardiologia   +17 more
wiley   +1 more source

Surgical lead extraction for pacemaker infection with tricuspid valve repair: A case report. [PDF]

SAGE Open Med Case Rep
Hisata Y, Taguchi S, Furukawa S, Koga Y, Yamamoto M, Yamada T.   +5 more
europepmc   +1 more source

Cilostazol in patients with heart failure and preserved ejection fraction—The CLIP‐HFpEF trial

ESC Heart Failure, Volume 12, Issue 2, Page 1437-1446, April 2025.
• Cilostazol is an oral PDE‐3 inhibitor that may have advantageous effects in heart failure with preserved ejection fraction (HFpEF). • Cilostazol significantly improved short‐term heart failure‐related health status scores (KCCQ‐12) and NT‐proBNP levels when compared to placebo.
Norman Aiad, Jeanne du Fay de Lavallaz, Michael J. Zhang, Thanat Chaikijurajai, Bo Ye, Prabhjot S. Nijjar, Julie A. Lahiri, Cindy M. Martin, Tamas Alexy, Markus Meyer   +9 more
wiley   +1 more source

Time relation between two pacemakers in atrial parasystole.

, 1967
S.D. Moulopoulos, D.A. Sideris
openalex   +1 more source